1 of 13

BIOTECHNOLOGY AND ITS APPLICATIONS

2 of 13

The critical areas of biotechnology

  • Providing the best catalyst in the form of improved organism usually a microbe or pure enzyme.
  • Creating optimal condition through engineering for a catalyst to act.
  • Downstream processing technologies to purify the protein/organic compound.
  • BIOTECHNOLOGICAL APPLICATIONS IN AGRICULTURE:
  • Plants, bacteria, fungi and animals whose genes have been altered by manipulation are called Genetically Modified Organisms (GMO).
  •  
  • Advantages of Genetic Modification in plants.
    • Made crops more tolerant to abiotic stresses (cold, drought, salt, heat)
    • Reduce reliance on chemical pesticides (pest resistant crop)
    • Helped to reduce post harvest losses.
    • Increased efficiency of mineral usage by plants.
    • Enhanced nutritional values of food e.g. vitamin A enriched rice.

3 of 13

Bt Cotton

  • Some strains of Bacillus thuringiensis produce proteins that kill certain insects such as lepidopterans(tobacco budworm, armyworm), coleopterans (beetles) and dipterans (flies, mosquitoes).
  • B.thuringiensis forms protein crystals during a particular phase of their growth. These crystals contain a toxicinsecticidal protein.
  • These proteins are present in inactive protoxin form, but become active toxin in the alkaline pH of insect gut.
  • The activated toxin binds to the surface of midgut epithelial cells and create pores that cause cell swelling and lysis and eventually cause death of insect
  • Specific Bt toxin genes were isolated form B. thuringiensis and genetically transferred to several plants such as cotton.
  • Crystal proteins are produced by a gene called cry in B. thuringiensis.
  • The protein coded by genes cryIAc and cryIIAb control the cotton bollworms.
  • The protein coded by gene cryIAb controls corn borer.

4 of 13

Pest resistant plants

  • Several nematodes parasitize a wide variety of plants and animals including human beings.
  • A nematode Meloidegyne incognitia infects the root of tobacco plants and causes a great reduction in yield.
  • Strategy based on RNA interference (RNAi) prevents this infestation.
  • Process by which double-stranded RNA (dsRNA) directs sequence-specific degradation of mRNA

5 of 13

Steps of RNA interference

  • Double stranded RNA is produced endogenously or exogenously.
  • Using Agrobacterium vectors nematode specific genes were introduced into the host plant (tobacco plant).
  • Introduction of DNA produces both sense and antisense RNA in the host.
  •  These two RNA’s being complementary to each other formed a double stranded (dsRNA) that initiated RNAi.
  • The dsRNA injected into the host plant from outside called exogenous dsRNA.
  • The dsRNAs are cleaved into 21-23 nt segments (“small interfering RNAs”, or siRNAs) by an enzyme called Dicer.
  • siRNAs are incorporated into RNA-induced silencing complex (RISC) 
  • Guided by base complementarity of the siRNA, the RISC targets mRNA for degradation.
  • The consequence was that the parasite could not survive in a transgenic host.

6 of 13

BIOTECHNOLOGICAL APPLICATIONS IN MEDICINE

  • Biotechnology enables mass production of safe and more effective therapeutic drugs.
  • Recombinant therapeutics does not induce unwanted immunological responses as is common in case of similar products isolated from non-human sources.
  • At present around 30 recombinant therapeutics, approved for human-use.

7 of 13

Genetically Engineered Insulin

  • Taking insulin at regular interval of time is required for adult-onset diabetes.
  • Previously the source of insulin was the slaughtered cattle and pigs.
  • This insulin caused allergy in some patients.
  • Each insulin made of two short polypeptide chains; chain A and chain B that are linked together by disulphide linkage.
  • Insulin synthesized in pancreas as pro-hormone which is a single polypeptide with an extra stretch called C-peptide.
  • C-peptide is removed during matured insulin.
  • In 1983 Eli Lilly an American company prepared two DNA sequences corresponding to A and B, chains of human insulin and introduced them in plasmids of E.coli to produce insulin chains.
  • Chain A and chain B produced separately, extracted and combined by creating disulfide bonds to form mature human insulin.

8 of 13

Gene therapy

  • Gene therapy is an attempt to cure hereditary or genetic diseases.
  • Genes are inserted into a person’s cells and tissue to treat the disease.
  • The first clinical gene therapy was given in 1990 to a 4-yr old girl with adenosine deaminase (ADA) deficiency.
  • This enzyme is required for breakdown of deoxyadenosine into uric acids.
  • In the absence of ADA toxic deoxyadenosine is accumulated and destroy the infection fighting immune cells called T-cells and B-cells.
  • This disorder is caused due to the deletion of the gene for adenosine deaminase in chromosome

9 of 13

Treatment:

  • Treated by bone marrow transplantation.
  • Enzyme replacement therapy, involving repeated injections of the ADA enzyme
  • Lymphocytes from the blood of the patient are grown in a culture. A functional ADA cDNA is then introduced into these lymphocytes and returned into the body.
  • The patient required periodic infusion of genetically engineered lymphocytes because these cells are not immortal.
  • Functional ADA cDNA introduced into cells at early embryonic stages, could be the permanent cure.

10 of 13

Molecular diagnosis

  • Early detection of disease is not possible by conventional methods (serum and urine analysis)
  • Molecular diagnosis techniques:
  • Recombinant DNA technology.
  • Polymerase chain reaction (PCR)
  • Enzyme linked Immuno-sorbent Assay (ELISA)
  • Very low concentration of a bacteria or virus can be amplified and detected by PCR.
  • It used to detect genetic disorders.
  • PCR is use full to mutation in genes in suspected cancerous patient:
    • A single stranded DNA or RNA tagged with radioactive molecule (probe) is allowed to hybridize to its complementary DNA in a clone of cells followed by detection using autoradiography.
    • The clone having mutated gene unable make complementary bonding of probe, hence not appears in photographic film.

11 of 13

TRANSGENIC ANIMALS

  • Animals that have an alien DNA which able to express in it is called transgenic animals.
  • Reasons for creation of transgenic animals:
  • Normal physiology and development:
    • Transgenic animals are specifically designed to allow study of:
      • How the genes are regulated.
      • How the gene affects normal functioning of body
      • How it affects growth and development. E.g. insulin like growth factor.
    • The animals made transgenic to know the biological effect and result.

12 of 13

Study of disease:

    • Transgenic animals are designed to understand how genes contribute to the development of disease like cancers, cystic fibrosis, rheumatoid arthritis and Alzheimer’s.

Biological products:

    • Transgenic animals are used to produce biological product of human interest:
      • α-1-antitrypsin used to treat emphysema.
      • Proteins for treatment for PKU and cystic fibrosis.
      • Transgenic cow Rosie, produce human protein enriched milk (2.4 gm/lit. human α-lactalbumin)

Vaccine safety:

    • Transgenic mice are being developed and use in testing the safety of vaccines before they are used for humans.
    • Polio vaccine is tested in mice.

Chemical safety testing

    • This is also known as toxicity/safety testing.
  • Transgenic animals are made to known the effect of toxic chemicals

13 of 13

ETHICAL ISSUES

  • GEAC (Genetic Engineering Approval Committee) set up by Indian Govt, which will make decisions regarding validity of GM research and safety of introducing GM-organisms for public services.
  • patent is the right granted by a government to an inventor to prevent others from commercial use of his invention.
  • Patents granted for biological entities and for products derived from them; these patents are calledbiopatents.
  • 27 documented varieties of Basmati are grown in India.
  • Biopiracy is the term used to refer to the use/exploit or patent, of biological resources by multinational companies and other organizations without proper authorization from the countries and people concerned without compensatory payment.